Drugs that contain Abaloparatide
1. List of Tymlos drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8748382 | RADIUS HEALTH INC | Method of drug delivery for bone anabolic protein |
Oct, 2027
(4 years from now) | |
| US8148333 | RADIUS HEALTH INC | Stable composition comprising a PTHrP analogue |
Nov, 2027
(4 years from now) | |
| US7803770 | RADIUS HEALTH INC | Method of treating osteoporosis comprising administration of PTHrP analog |
Apr, 2031
(7 years from now) | |
| USRE49444 | RADIUS HEALTH INC | Method of treating osteoporosis comprising administration of PTHrP analog |
Apr, 2031
(7 years from now) | |
| US10996208 | RADIUS HEALTH INC | Abaloparatide formulations and methods of testing, storing, modifying, and using same |
Apr, 2038
(14 years from now) | |
| US11255842 | RADIUS HEALTH INC | Methods for detecting neutralizing antibodies to parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHRP) analog |
Jan, 2040
(16 years from now) | |
| Exclusivity | Exclusivity Expiration |
|---|---|
| M (M) | Sep 20, 2024 |
| New Indication (I) | Dec 19, 2025 |
Market Authorisation Date: 28 April, 2017
Treatment: Method of treating postmenopausal women with osteoporosis at high risk for fracture.; Treatment to increase bone density in men with osteoporosis at high risk for fracture; Use for detecting neutraliz...
Dosage: SOLUTION;SUBCUTANEOUS
TYMLOS family patents
15
United States
5
Korea, Republic of
3
China
3
Brazil
3
European Union
2
Spain
2
Denmark
2
Canada
2
Singapore
2
Japan
2
Israel
2
Portugal
2
Australia
1
IB
1
Hong Kong
1
RS
1
Poland
1
Russia
1
Ukraine
1
Norway
1
New Zealand
1
Croatia
1
Cyprus
1
Mexico
1
Colombia
1
Lithuania
1
Slovenia
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic